Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 16, 2020 Filed Nov 17, 2020 20:25 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 6,400 | $39.87 | $255,168.00 |
DisclosureSEC source: 0001127602-20-029221 · form4.xml · nonDerivative · entry 3 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:25 UTC |
Berge Terence MVP-Corporate Controller
|
Tax withholdingCommon Stock | 2,723 | $98.21 | $267,425.83 |
DisclosureSEC source: 0001127602-20-029221 · form4.xml · nonDerivative · entry 2 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,912 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:25 UTC |
Berge Terence MVP-Corporate Controller
|
Exercise / conversionCommon Stock | 3,600 | $51.30 | $184,680.00 |
DisclosureSEC source: 0001127602-20-029221 · form4.xml · nonDerivative · entry 1 Berge Terence M · CIK 0001635424 · VP-Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 20:33 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 1,589 | $95.00 | $150,955.00 |
DisclosureSEC source: 0001127602-20-029227 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,609 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 9,000 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · derivative · entry 6 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,700 Underlying: Common Stock · 9,000 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 446 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · derivative · entry 5 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,700 Underlying: Common Stock · 446 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 9,000 | $94.30 | $848,733.30 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 4 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.25 to $94.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 9,000 | $39.87 | $358,830.00 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 446 | $94.52 | $42,156.10 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $94.537. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 20:06 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 446 | $39.87 | $17,782.02 |
DisclosureSEC source: 0001127602-20-029088 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 13:56 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
SaleCommon Stock | 456 | $93.96 | $42,847.58 |
DisclosureSEC source: 0001127602-20-028882 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,881 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,900 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · derivative · entry 16 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,600 Underlying: Common Stock · 1,900 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,400 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · derivative · entry 15 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,200 Underlying: Common Stock · 5,400 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · derivative · entry 14 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,940 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · derivative · entry 13 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,940 Underlying: Common Stock · 4,940 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,880 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · derivative · entry 12 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,880 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 1,900 | $95.10 | $180,696.84 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 11 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,198 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.87 to $95.375. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 1,900 | $78.76 | $149,644.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 10 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 5,400 | $94.76 | $511,705.08 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 9 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,198 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 5,400 | $59.96 | $323,784.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 8 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 5,000 | $94.75 | $473,755.50 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 7 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,198 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.375. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 5,000 | $41.93 | $209,650.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 376 | $95.52 | $35,914.24 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,198 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.51 to $95.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
SaleCommon Stock | 4,564 | $94.79 | $432,608.78 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,574 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.50 to $95.48. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 4,940 | $39.87 | $196,957.80 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,138 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Tax withholdingCommon Stock | 3,291 | $95.17 | $313,204.47 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,198 Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 21:37 UTC |
KENNEDY JOHN JEDVP GM CET
|
Exercise / conversionCommon Stock | 4,880 | $51.30 | $250,344.00 |
DisclosureSEC source: 0001127602-20-028994 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · VP GM CET 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 554 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,146 Underlying: Common Stock · 554 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 554 | $94.31 | $52,250.12 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.26 to $94.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 18:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 554 | $39.87 | $22,087.98 |
DisclosureSEC source: 0001127602-20-028735 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 617 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 16:29 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,960 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-20-028727 · form4.xml · derivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,960 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 16:29 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Tax withholdingCommon Stock | 3,832 | $94.08 | $360,514.56 |
DisclosureSEC source: 0001127602-20-028727 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,708 Read SEC document |
| November 10, 2020 Filed Nov 12, 2020 16:29 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
Exercise / conversionCommon Stock | 4,960 | $51.30 | $254,448.00 |
DisclosureSEC source: 0001127602-20-028727 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:31 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 2,000 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-20-028652 · form4.xml · derivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:31 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 1,544 | $92.84 | $143,344.96 |
DisclosureSEC source: 0001127602-20-028652 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,337 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 22:31 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 2,000 | $51.30 | $102,600.00 |
DisclosureSEC source: 0001127602-20-028652 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2020 Filed Nov 10, 2020 01:55 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 500 | $81.82 | $40,910.00 |
DisclosureSEC source: 0001127602-20-028543 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherSars (Stock Appreciation Rights) · Derivative | 11,000 | $55.42 Strike: $55.42 | $609,620.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 6 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 11,000 shares Expires 2025-05-11 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F5 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherOptions To Purchase Common Stock · Derivative | 1,998 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 5 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,442 Underlying: Common Stock · 1,998 shares Expires 2026-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherOptions To Purchase Common Stock · Derivative | 11,960 | $0.00 Strike: $59.96 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 4 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,040 Underlying: Common Stock · 11,960 shares Expires 2028-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F4 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherOptions To Purchase Common Stock · Derivative | 8,865 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,435 Underlying: Common Stock · 8,865 shares Expires 2027-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F3 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherOptions To Purchase Common Stock · Derivative | 9,840 | $0.00 Strike: $78.76 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,160 Underlying: Common Stock · 9,840 shares Expires 2029-03-01 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| October 30, 2020 Filed Oct 30, 2020 20:05 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
OtherOptions To Purchase Common Stock · Derivative | 8,050 | $0.00 Strike: $97.69 | $0.00 |
DisclosureSEC source: 0001127602-20-027714 · form4.xml · derivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,950 Underlying: Common Stock · 8,050 shares Expires 2030-03-02 F1 · kind: Assignment of options to Mr. Shagory's former spouse as approved by Compensation Committee. F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| September 30, 2020 Filed Oct 30, 2020 16:42 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 22 | $74.74 | $1,644.28 |
DisclosureSEC source: 0001127602-20-027698 · form5.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 15:55 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 895 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025715 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 895 shares Expires 2029-09-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 23, 2020 Filed Sep 25, 2020 15:55 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 895 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-025715 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 20:10 UTC |
Concannon BrianDirector
|
SaleCommon Stock | 3,036 | $89.31 | $271,145.16 |
DisclosureSEC source: 0001127602-20-025035 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.16 to $89.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Cancel Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,200 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 4,200 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
SaleCommon Stock | 4,200 | $85.88 | $360,696.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $85.87 to $85.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:39 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 4,200 | $41.93 | $176,106.00 |
DisclosureSEC source: 0001127602-20-024781 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.